X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2017 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
Compare Pfizer with Fresenius Kabi Onco. - Equitymaster
  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

PFIZER vs FRESENIUS KABI ONCO. - Comparison Results

PFIZER    Change

Pfizer India is a 71% subsidiary of the world's largest pharmaceuticals company Pfizer Inc. Pfizer derives a larger share of its revenues from the pharmaceuticals division (81%). The company also has presence in the animal health (13%) and clinical d... More

FRESENIUS KABI ONCO. 
   Change

Fresenius Kabi Oncology is the erstwhile Dabur Pharma, which was incorporated in March 2003. The company is a leading player in oncology in India and the international markets. Fresenius Kabi Oncology operates in the regulated markets namely the US a... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    PFIZER FRESENIUS KABI ONCO. PFIZER/
FRESENIUS KABI ONCO.
 
P/E (TTM) x 24.8 22.1 112.1% View Chart
P/BV x 3.9 3.1 126.7% View Chart
Dividend Yield % 0.8 0.0 -  

Financials

 PFIZER   FRESENIUS KABI ONCO.
EQUITY SHARE DATA
    PFIZER
Mar-16
FRESENIUS KABI ONCO.
Mar-13
PFIZER/
FRESENIUS KABI ONCO.
5-Yr Chart
Click to enlarge
High Rs2,724176 1,547.7%   
Low Rs1,61179 2,052.2%   
Sales per share (Unadj.) Rs440.937.7 1,169.9%  
Earnings per share (Unadj.) Rs48.75.1 956.1%  
Cash flow per share (Unadj.) Rs75.86.7 1,127.0%  
Dividends per share (Unadj.) Rs15.000-  
Dividend yield (eoy) %0.70-  
Book value per share (Unadj.) Rs462.942.5 1,088.2%  
Shares outstanding (eoy) m45.75158.23 28.9%   
Bonus/Rights/Conversions ---  
Price / Sales ratio x4.93.4 145.6%   
Avg P/E ratio x44.525.0 178.2%  
P/CF ratio (eoy) x28.618.9 151.1%  
Price / Book Value ratio x4.73.0 156.5%  
Dividend payout %30.80-   
Avg Mkt Cap Rs m99,16320,135 492.5%   
No. of employees `0002.91.2 250.8%   
Total wages/salary Rs m2,758703 392.1%   
Avg. sales/employee Rs Th6,981.75,176.2 134.9%   
Avg. wages/employee Rs Th954.5610.4 156.4%   
Avg. net profit/employee Rs Th771.1699.6 110.2%   
INCOME DATA
Net Sales Rs m20,1705,963 338.3%  
Other income Rs m85718 4,763.3%   
Total revenues Rs m21,0285,981 351.6%   
Gross profit Rs m4,3101,430 301.4%  
Depreciation Rs m1,239258 480.3%   
Interest Rs m5-26 -20.0%   
Profit before tax Rs m3,9231,216 322.6%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m99-68 -145.2%   
Tax Rs m1,794342 524.4%   
Profit after tax Rs m2,228806 276.4%  
Gross profit margin %21.424.0 89.1%  
Effective tax rate %45.728.1 162.6%   
Net profit margin %11.013.5 81.7%  
BALANCE SHEET DATA
Current assets Rs m16,2995,102 319.5%   
Current liabilities Rs m7,5942,385 318.3%   
Net working cap to sales %43.245.6 94.7%  
Current ratio x2.12.1 100.4%  
Inventory Days Days65150 43.5%  
Debtors Days Days26113 22.7%  
Net fixed assets Rs m8,6225,148 167.5%   
Share capital Rs m458158 289.2%   
"Free" reserves Rs m20,7226,556 316.1%   
Net worth Rs m21,1806,732 314.6%   
Long term debt Rs m25952 2.6%   
Total assets Rs m29,13710,388 280.5%  
Interest coverage x755.5-45.8 -1,650.4%   
Debt to equity ratio x00.1 0.8%  
Sales to assets ratio x0.70.6 120.6%   
Return on assets %7.77.5 102.1%  
Return on equity %10.512.0 87.9%  
Return on capital %19.014.6 130.1%  
Exports to sales %0.174.5 0.1%   
Imports to sales %17.524.8 70.6%   
Exports (fob) Rs m124,441 0.3%   
Imports (cif) Rs m3,5261,477 238.6%   
Fx inflow Rs m525,298 1.0%   
Fx outflow Rs m1401,772 7.9%   
Net fx Rs m-883,525 -2.5%   
CASH FLOW
From Operations Rs m3,4361,274 269.7%  
From Investments Rs m-6,991-1,204 580.5%  
From Financial Activity Rs m-619-196 315.6%  
Net Cashflow Rs m-4,174-126 3,304.4%  

Share Holding

Indian Promoters % 0.0 0.0 -  
Foreign collaborators % 63.9 81.0 78.9%  
Indian inst/Mut Fund % 7.5 0.3 2,500.0%  
FIIs % 4.9 9.6 51.0%  
ADR/GDR % 0.0 0.0 -  
Free float % 23.7 9.1 260.4%  
Shareholders   85,207 42,599 200.0%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare PFIZER With:   TORRENT PHARMA  ALKEM LABORATORIES  AJANTA PHARMA  SANOFI INDIA  ALEMBIC PHARMA  

Compare PFIZER With:   ACTAVIS (US)  ADCOCK INGRAM (S. Africa)  MYLAN (US)  TEVA PHARMA (Israel)  



Today's Market

Indian Indices Trade Marginally Higher; Pharma Sector Up 2.4%(11:30 am)

Stock markets in India are presently trading near the dotted line with positive bias. Sectoral indices are trading on a mixed note with stocks in the healthcare sector.

Related Views on News

Sun Pharma: Bottomline Slips into the Red Amidst Challenging Environment (Quarterly Results Update - Detailed)

Aug 14, 2017

A challenging environment and one-time expense pushes Sun Pharma into a loss in the first quarter.

Lupin: Bigger Challenges or Bigger Margin of Safety? (Quarterly Results Update - Detailed)

Aug 14, 2017

GST impact coupled with price erosion in US leads to lower profits for the quarter.

Dr Reddy's: US Pressure Continues to Haunt (Quarterly Results Update - Detailed)

Aug 8, 2017

Profits plunge due to higher raw material costs.

Biocon: Lower Licensing Income Leads to Muted Growth for the Quarter (Quarterly Results Update - Detailed)

Jun 23, 2017

Net Profit lower due to exceptional items in the previous year.

The Power of 5 Minutes (The 5 Minute Wrapup)

Jun 16, 2017

Here's what you can expect from The 5 Minute Wrapup in the coming months and years.

More Views on News

Most Popular

This Small Cap Can Drive Chinese Players Out of India (and Make a Fortune in the Process)(The 5 Minute Wrapup)

Aug 17, 2017

A small-cap Indian company with high-return potential and blue-chip-like stability is set to supplant the Chinese players in this niche segment.

Dear PM Modi, India is Already Land of Self-Employed, and It Ain't Working(Vivek Kaul's Diary)

Aug 21, 2017

Most Indians who cannot find jobs, look at becoming self-employed.

It's the Best Time to Buy IT Stocks(Daily Profit Hunter)

Aug 16, 2017

The IT Sector could be in an uptrend till February 2019. Are you prepared to ride the trend?

5 Steps To Become Financially Independent(Outside View)

Aug 16, 2017

Ensure your financial Independence, and pledge to start the journey towards financial freedom today!

Think Twice Before You Keep Money In A Savings Bank Account(Outside View)

Aug 22, 2017

Post demonetisation, a cut in bank savings deposits rates was in the offing.

More

Become A Smarter Investor In
Just 5 Minutes

Multibagger Stocks Guide 2017
Get our special report, Multibagger Stocks Guide (2017 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

PFIZER SHARE PRICE


Aug 24, 2017 12:52 PM

TRACK PFIZER

COMPARE PFIZER WITH

MARKET STATS